Cartesian Therapeutics
RNAC
RNAC
79 hedge funds and large institutions have $144M invested in Cartesian Therapeutics in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
17% less capital invested
Capital invested by funds: $174M → $144M (-$30.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
79
Holding in Top 10
1
Calls
$361K
Puts
$97K
Top Buyers
| 1 | +$3.97M | |
| 2 | +$2.54M | |
| 3 | +$2.42M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.62M |
| 5 |
Two Sigma Advisers
New York
|
+$1.52M |
Top Sellers
| 1 | -$3.25M | |
| 2 | -$2.84M | |
| 3 | -$1.59M | |
| 4 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$1.54M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.49M |